VitD3 Supplementation in Patients With Multiple Myeloma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
Multiple Myeloma
Interventions
DRUG

Lenalidomide

For first three cycles, taken orally once daily for 28 days at 10mg/day dose. After cycle 4, taken orally once daily at 15 mg/day dose

DRUG

Maintenance Vitamin D

After replacement of vitamin D deficiency with weekly cholecalcefirol 50,000 units untill levels are \> 30, will start maintenance therapy with Monthly replacement with 50,000 IU

DRUG

No maintenance Vitamin D

After replacement of vitamin D deficiency with weekly cholecalcefirol 50,000 units untill levels are \> 30, stop replacement and continue monitoring levels

Trial Locations (1)

30912

RECRUITING

Georgia Cancer Center at Augusta University, Augusta

All Listed Sponsors
lead

Amany Keruakous, MD, MS.

OTHER